Abstract
The outbreak of COVID-19 has introduced a significant stress on the healthcare systems of many countries. The availability of quick and reliable screening methodologies can be regarded as the keystone approach to mitigate the spread of the infection until mass vaccination campaigns will be made available to the population. In this scenario, robotics technology can serve as a substantial help in clinical laboratories to speed up the activities.This work describes in the details a collaborative robotics application developed in partnership with a clinical hospital and a robot manufacturer to partly automate SARS-CoV-2 quantitative serological tests. This technology can be particularly beneficial for small laboratory facilities to alleviate technicians from performing repetitive operations. By automating part of the operations, the overall throughput can be increased of 66%, while the amount of possibly harmful pipetting activities performed by the human can be reduced of 62%.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
